BNP Paribas Easy Low Carbon 100 Eurozone PAB UCTIS ETF (LCEZ) ニュース

Thanks.

There's just too many red flags IMO. They've issued too many PR's to count, and not one has come to fruition or is even spoken about again. Stuff like that simply doesn't happen at good companies.

Lol wants beer and cigarettes but could probably buy a tavern with patience 😂

They only did the analysis for three patients among 40 enrolled patients.

It is not interesting. It is exciting. Recall I used to post again and again about variation of gene expressions of over 30 thousand from the poly-iclc trial. They did the same for the combo trial for three pat

Lakota, interesting weekend, and an above average start this Monday morning. Lots to be “chewing on” this Thanksgiving Day, for sure!

Lakota, interesting weekend, and an above average start this Monday morning. Lots to be “chewing on” this Thanksgiving Day, for sure!

He believes in medicine.  This is a $15 stock in 3 years 

A quarter of FNMA's earnings could buy whole company itself outright, which shows just how undervalued or screwed by the government it is.

KULR........RGTI......DOUG......MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936

at least the gap is taken care of.

$RFHRF $RFR.CN - "Green metals are key to a sustainable future, and at Renforth Resources, we're proud to lead efforts advancing clean energy solutions. Our Quebec-based Malartic Metals Package positions us to meet the growing demand for essential green metals."

https://x.com/Renforth

"And when you stand praying, if you hold anything against anyone, forgive him, so that your Father in heaven may forgive you your sins."
—Mark 11:25

Because it’s a sampling.

To investigate this mechanism of immunotherapy resistance, we performed single-cell RNA-sequencing (scRNAseq) on pre- and post-vaccination tumor-infiltrating immune cells from three recurrent GBM patients enrolled in the ATL-DC + neo-aPD1 clinical trial.

Crazy seller

"This leaves only TauRx and Blarcamesine as key contenders"

There is also Alzheon, they had a phase 3 which finished in June, still waiting on the results. It's on a specific subset though(15% or so of AD patients) however they also have a more broad AD trial I think around phase 2 so

You have mail.

Look at $INUV WHILE CHEAP ADDER
https://investorshub.advfn.com/uimage/uploads/2024/11/25/kqsbastock_will_trend.jpg🤘🏻😍

todays volume so far are longs and many bought in this am, got rid of some flippers which always helps lol

Look at $INUV WHILE CHEAP ADDER
https://investorshub.advfn.com/uimage/uploads/2024/11/25/kqsbastock_will_trend.jpg🤘🏻😍

Alpine case thrown out by fed court last friday ( the emergency CDO) they are still facing expulsion and will have to go through NAC and SEC but the emergency expulsion failed....i guess Ham and Ferrand and Ace didnt testify with their intimate knowledge of over 300 million Naked Shares Short??? Sh

$ILLR represents the future of music-tech innovation. With Triller’s AI-driven tools empowering creators worldwide, it’s reshaping how music, video, and media are consumed. As the platform scales its user base and deepens its industry partnerships, $ILLR is poised to deliver value for investors aimi

Good morning lol

I was counting both Fannie and Freddie.